JPMorgan Chase & Co. Increases Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target to $80.00
MarketBeat
The Wildfire Calendar Has Changed; Has Yours?
PR Newswire
RingCentral Chief Accounting Officer Sells 5,623 Shares
Nasdaq News: Markets
Is Oklo the Next Great AI Story -- Or Just Nuclear Hype?
Nasdaq News: Markets
Cathie Wood's Ark Innovation Fund Returned 17% Over the Past Year. Is It Still a Buy After Years of Underperformance?
Fool.com Headlines
Gorilla Sinks 11% Despite Guiding 2027 Revenue Up to 29% Above Consensus, Evolv Technologies and Ambarella Tick Up
24/7 Wall St.
